Beam Therapeutics Inc.

BEAM · Healthcare · · USD

31.75 USD

0.00 (-1.76%)

● Updated 2026-05-12 12:52 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score STRONG BUY Short-term (Swing)

/ 100

Technical 100

Trend & RS 98

Momentum 80

Fundamental (0%) 67

Macro 65

Liquidity 40

Component	Score	Weight
Technical	100.0	40%
Trend & RS	98.0	20%
Momentum	80.0	20%
Fundamental	66.7	0%
Macro	65.1	15%
Liquidity	40.2	5%

Trade Setup

Entry	31.75
Stop Loss	27.57 (13.2%)
Target 1 (1:1)	35.93 (+13.2%)
Target 2 (2:1)	40.11 (+26.3%)

ATR(14)	2.09 (6.6%)
Risk per Share	4.18
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	76.7	+1.07
Momentum	80.0	+1.20
Quality	36.2	-0.55
Composite	64.3

Quality Scores

Piotroski F-Score 3 /9 — Weak

✗ ✗ ✗ ✗ ✓ ✓ ✗ ✗ ✓

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score 6.66 — Safe Zone

Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Undervalued

Metric	Stock	Sector	vs Peers
P/E Ratio	N/A	22.0	Inline
P/B Ratio	2.7	4.0	Below

Comparing against Healthcare median multiples.

Trading at a discount to sector peers — potential value opportunity.

Position Sizing — Kelly Criterion

4.5%

Recommended Size

55.5%

Full Kelly

27.75%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 87/100. Estimated win rate 66%, avg win 10.2%, avg loss 3.3%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG BUY

Bullish Signals

Bearish Signals

57.68

RSI(14)

1.1482

MACD

Relative Strength (RS) IMPROVING

/ 99

RS Rating

✓ O'Neil PASS (≥80)

RS vs SPY	↑ RISING (+9.6% vs SPY 3M)
RS vs Sector	OUTPERFORMING (Healthcare)
RS New High	No (53d since high)
Sector Outperformance	+18.9% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

IMPROVING: Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.

Technical Indicators

Indicator	Value	Signal
Rsi	57.68	NEUTRAL
Macd	1.1482	BULLISH
Ma Cross	27.47 / 25.33	GOLDEN CROSS
Trend Short		ABOVE SMA50
Trend Long		ABOVE SMA200
Bollinger		MIDDLE
Volume	1.11x	NORMAL

Key Levels

Level	Price
52-Week High	36.44
Bollinger Upper	33.02
SMA(200)	25.33
SMA(50)	27.47
SMA(20)	30.53
Current Price	31.75
Bollinger Lower	28.04
52-Week Low	15.35
ATR(14)	2.09

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

ACCUMULATION A Confidence

50%

Selling Climax

Acc: 2.0 | Dist: 0.0 | Markup: 2.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-05-05	Normal	0.94x	Normal bar — no special VSA pattern
2026-05-06	Normal	1.01x	Normal bar — no special VSA pattern
2026-05-07	Normal	0.81x	Normal bar — no special VSA pattern
2026-05-08	Normal	1.31x	Normal bar — no special VSA pattern
2026-05-11	Normal	1.11x	Normal bar — no special VSA pattern

Ichimoku Cloud BULLISH

Line	Value	Status
Tenkan-sen (9)	31.44	Above Kijun
Kijun-sen (26)	28.91	Base line
Senkou A	30.17	Leading span A
Senkou B	28.00	Leading span B
Cloud	28.00 – 30.17	Bullish (Green)
Price vs Cloud	31.75	Above Cloud
Chikou Span	24.23	Bullish
Alignment Score	4/4	BULLISH